Navigation Links
Least Aggressive Breast Cancer Still Poses Long-Term Risk, Study Finds
Date:9/18/2012

TUESDAY, Sept. 18 (HealthDay News) -- The most common and least aggressive form of breast cancer still poses a risk of death more than 10 years after a woman is diagnosed with the disease, according to a new long-term study.

The findings could affect how doctors treat women with this type of breast cancer, the researchers said.

Their 21-year study of nearly 1,000 women in California found that molecular subtypes of breast cancer were important independent predictors of death from breast cancer. In particular, women with luminal A tumors (a subtype of breast cancer generally believed to have the best prognosis) were still at risk for death from the cancer more than 10 years after their diagnosis.

The researchers at Kaiser Permanente Southern California also found that women with HER2-enriched and luminal B tumors were about twice as likely to die from breast cancer than those with luminal A tumors. That result is consistent with previous research.

"The findings of this study indicate that it is important to consider breast cancer molecular subtypes in determining the optimal treatment for women with breast cancer," study author Reina Haque said in a Kaiser news release. "Women with luminal A tumors -- the least aggressive but most common cancerous breast tumor -- could benefit from extended treatment to improve their chances for long-term survival."

The study appeared Sept. 18 in the journal Cancer Epidemiology, Biomarkers & Prevention.

Breast cancer tumors often are divided into four molecular subtypes, the researchers explained in the news release:

  • Luminal A, which tends to have the best prognosis with fairly high survival rates.
  • Luminal B, which typically occurs in younger women and has a poor prognosis.
  • Basal-like subtype, which also tends to occur in younger women, as well as in black women, and has a poor prognosis.
  • HER2-enriched subtype, which has a fairly poor prognosis and is prone to early and frequent recurrence and metastases (the spread of the disease to other parts of the body).

Of the four subtypes, luminal A accounts for between 42 percent and 59 percent of all breast cancer cases, the release noted.

"These and earlier findings strongly support molecular subtypes as important independent predictors of breast cancer mortality," Haque said. "It is important for women with breast cancer -- even those diagnosed with the least aggressive form of the disease -- to be an advocate for their own health and speak to their doctors about treatment options."

More information

The American Cancer Society has more about breast cancer.

-- Robert Preidt

SOURCE: Kaiser Permanente, news release, Sept. 18, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study finds least aggressive form of breast cancer still poses risk for death years later
2. TAVI improves quality of life in patients with severe aortic stenosis for at least 1 year
3. More Americans Have at Least 2 Chronic Health Issues: CDC
4. Lack of sleep found to be a new risk factor for aggressive breast cancers
5. Gene Might Predict Brain Tumors Aggressiveness
6. The making and unmaking of stem-like, aggressive breast cancer cells
7. Research identifies a promising new therapeutic target for aggressive breast cancer
8. Researchers study vaccine as potential weapon against aggressive brain tumors
9. New lipid screening guidelines for children overly aggressive, UCSF researchers say
10. Cell differentiation as a novel strategy for the treatment of an aggressive type of skin cancer
11. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Least Aggressive Breast Cancer Still Poses Long-Term Risk, Study Finds
(Date:1/18/2017)... ... ... Dr. Farhan Qureshi is an esteemed dentist who offers a full range of ... convenient office locations in Alexandria and Arlington, Virginia. Recently, Find Local Dentists has recognized ... This award confirms the fact that Dr. Qureshi’s patients have left highly favorable reviews ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World ... with the donation of cochlear implants. In February 2017, the first three children ... fair chance of leading an independent life. This engagement builds on the support ...
(Date:1/18/2017)... ... , ... Floundering on New Year’s resolutions? Need an excuse to get back ... The U.S. Apple Association agrees and recommends starting each day with apples, a ... heart disease. , The U.S. Apple Association – which represents apple growers and producers ...
(Date:1/17/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... in Miami, FL. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with ... magical moments that help everyone endure and pass through tough times, Dr. Bernie ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global artificial pancreas devices system market to grow at ... Artificial Pancreas Devices System Market 2016-2020, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:1/17/2017)... 2017 The interventional radiology products market is ... USD 6.35 billion in 2016, at a CAGR of ... this market are rising incidence of chronic diseases, rising ... The global interventional radiology products market is ... the basis of type, the stents segment is expected ...
(Date:1/17/2017)... , January 17, 2017 Management to ... TyrNovo, Ltd.   KIT-302 Development On Track For An ... FDA in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), ... on Monday, January 23 rd at 8:30am Eastern Time to discuss the ...
Breaking Medicine Technology: